Angélique Chevriaux
Centre Georges François Leclerc(FR)
Publications by Year
Research Areas
Immune cells in cancer, Cancer Immunotherapy and Biomarkers, Cancer Research and Treatments, Virus-based gene therapy research, Immune Cell Function and Interaction
Most-Cited Works
- → 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity(2010)1,212 cited
- → Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth(2012)766 cited
- → The receptor NLRP3 is a transcriptional regulator of TH2 differentiation(2015)396 cited
- → Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression(2012)324 cited
- → Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen(2016)256 cited
- → Cathepsin B Is Required for NLRP3 Inflammasome Activation in Macrophages, Through NLRP3 Interaction(2020)181 cited
- → HSP70 is a negative regulator of NLRP3 inflammasome activation(2019)107 cited
- → Monitoring HSP70 exosomes in cancer patients’ follow up: a clinical prospective pilot study(2020)105 cited
- → Induction of Transglutaminase 2 by a Liver X Receptor/Retinoic Acid Receptor α Pathway Increases the Clearance of Apoptotic Cells by Human Macrophages(2009)98 cited
- → Fluorouracil and bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): a single-arm phase 2 study(2018)88 cited